Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Journal of Gastroenterology|January 12, 2013
Multicolor lineage tracing methods and intestinal tumorsHirotsugu Yanai, Toshihiro Tanaka, Hiroo UenoGan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2016
[The Clinical Utility of Pegfilgrastim in Combination with Adjuvant FEC(100)and TC Chemotherapy for Breast Cancer]Hirotsugu Yanai, Kayoko Endo, Mayumi Matsumoto, et al.Plos One|September 24, 2021
Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancerKatsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, et al.BMC Cancer|March 7, 2021
Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancerKatsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, et al.Oncology Letters|May 16, 2022
Prognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancerKatsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, et al.Oncology Letters|March 7, 2022
Prognostic significance of adipophilin expression in biopsy specimens of patients with triple-negative breast cancerKatsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, et al.Oncology Letters|March 23, 2022
Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breastHirotsugu Yanai, Mitsuaki Ishida, Katsuhiro Yoshikawa, et al.Molecular and Clinical Oncology|March 7, 2022
Association between fatty acid synthase and adipophilin expression in triple-negative breast cancerKatsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, et al.Plos One|November 17, 2020
Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical studyKatsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, et al.Plos One|June 11, 2021
Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patientsKatsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, et al.Pageof 3